Integration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotropin-releasing hormone receptor antagonist
- 3 June 2008
- journal article
- Published by Elsevier BV in Toxicology
- Vol. 248 (1), 8-17
- https://doi.org/10.1016/j.tox.2008.03.002
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The Impact of the Nonpeptide Corticotropin-Releasing Hormone Antagonist Antalarmin on Behavioral and Endocrine Responses to StressEndocrinology, 1999
- Alternative testing systems for evaluating noncarcinogenic, hematologic toxicity.Environmental Health Perspectives, 1998
- In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammationEndocrinology, 1996
- Consensus agreement regarding protocol issues discussed during the mouse lymphoma workshop: Portland, Oregon, may 7, 1994Environmental and Molecular Mutagenesis, 1995
- High-resolution cytogenetic characterization of the L5178Y TK± mouse lymphoma cell lineMutation Research, 1989
- Cytogenetic characterization of the L5178Y TK+/− 3.7.2C mouse lymphoma cell lineMutation Research/Environmental Mutagenesis and Related Subjects, 1985
- Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/− mouse lymphoma cellsMutation Research, 1985
- Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed PatientsScience, 1984
- Cytogenetic analysis of the L5178Y/TK+/− → TK−/− mouse lymphoma mutagenesis assay systemMutation Research, 1981
- Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity testMutation Research/Environmental Mutagenesis and Related Subjects, 1975